Versions Compared


  • This line was added.
  • This line was removed.
  • Formatting was changed.


  1. Antitrust Statement (HL7 GOM §05.02):
    Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM). 
  2. Agenda Review
    1. Slot user-submitted topics into agenda
  3. Approve previous minutes by general consent: 

  4. HL7 Business Updates (TSC, Vocab, CMG, PC, etc.)
  5. External Updates (ONC, etc.)
  6. Review
    1. Project Proposals
    2. Project Scope Statements (enter "CO" for "Status")
  7. Project Updates
    1. C-CDA Roadmap - Errata Updates, changes, long-term plans
    2. C-CDA Web Publishing
    3. CDA profile on FHIR Composition
  8. User Submitted Topics (1 hour)

    NameTopicTime & Constraints

    Whoever is chairing

    Vote on and submit paperwork for withdraw of 3 Idle ballots:

    • HL7 CDA® R2 Implementation Guide: Consolidated CDA Templates for Clinical Notes; Unique Device Identifier (UDI) Templates, Release 1 - US Realm
    • HL7 CDA® R2 Implementation Guide: Questionnaire Response Document, Release 1 
    • HL7 CDA® R2 Implementation Guide: Structured Form Definition Document, Release 1

    Sean McIlvenna / Benjamin Flessner 

  9. Recurring Topics (30 minutes)
    1. STU Comments
    2. FHIR Tickets
      1. FHIR-32534
      2. FHIR-26606 Rob McClure - need Rob's help to figure this out
    3. Work on Clinical Document profile changes
      1. CDA to FHIR Alignment Table
      2. Profile in FHIR Spec